In this section, we focus on compounds that target the strongest nucleophiles Cys in mutant p53 in order to stabilize p53 native conformation and restore DNA binding, rescuing “wild-type like transcriptional functions” and leading to cell death and tumor suppression (Figure 6). The gene discussed is TP53; the disease is neoplasm.